Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Oncology
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Oncology
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Oncology
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Oncology
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Moderna
Biotech
Moderna’s norovirus vaccine plans in limbo in wake of ph. 3 miss
Moderna has scrapped plans to enroll a new cohort in a trial of its norovirus vaccine and instead will meet with regulators to decide on next steps.
Marissa Russo
Nov 6, 2026 9:51am
From RAS rivalry to leaked readouts, ESMO brought the data drama
Oct 27, 2026 8:00am
ESMO: Merck exec unruffled by ‘unfortunate’ cancer vax data leak
Oct 24, 2026 6:24am
ESMO: Merck and Moderna post phase 3 cancer vaccine data early
Oct 22, 2026 4:45pm
Bayer taps new chief medical officer—Chutes & Ladders
Oct 2, 2026 8:30am
Have Moderna, Merck kicked off a 'personalized med revolution'?
Sep 11, 2026 9:00am